Friday 2 December 2022

FDA Approves First-in-Class Microbiota-Based Live Biotherapeutic for C. Difficile Infection

FDA Approves First-in-Class Microbiota-Based Live Biotherapeutic for C. Difficile Infection submitted by /u/Maxcactus
[link] [comments]


from Health https://ift.tt/Bc32NK4
via IFTTT

No comments:

Post a Comment